Two Onc Docs

Exploring diagnosis, treatment, and prognostic factors of Acute Lymphoblastic Leukemia, including cytogenetics, molecular markers, targeted therapies, and toxicities. Emphasis on differentiating between B-cell & T-cell types, advanced treatment options like CAR-T therapies, and key takeaways for effective management.

Explore the diagnosis, mutations, and treatment options for gastrointestinal stromal tumors (GIST) in this episode. Learn about the effectiveness of tyrosine kinase inhibitors, medication use in high-risk patients, and the role of adjuvant matinev in surgery and therapy selection for GIST.

Explore the best study plans and techniques used by fellows in hematology/oncology for board exams. Discover personalized strategies and resources tailored to individual learning styles. Delve into essential video resources and question banks, with a spotlight on the ASH review series and hemonquestions.com for detailed explanations. Learn effective strategies that emphasize consistency, flexibility, and high-yield topics, ensuring success in real-world oncology scenarios.

Kickstarting with a warm reintroduction, the hosts share their passion for hematology and oncology. They delve into the deep, meaningful connections formed with patients, emphasizing the fulfillment this brings to their challenging roles. The discussion highlights the complexity of modern cancer care, focusing on innovative therapies like immunotherapy and the importance of research. They also explore various career paths within the field, showcasing the benefits of multidisciplinary collaboration and hinting at future resources for aspiring professionals.

Explore the classification of gliomas like oligodendrogliomas and astrocytomas, emphasizing the significance of glioblastoma multiforme (GBM). Learn about key markers like IDH1 mutation and treatment approaches for recurrent GVM. Dive into management strategies for gliomas and meningiomas in primary CNS tumors, highlighting the role of mutations, methylation, and grade differentiation in treatment.

Dive into the world of Chronic Lymphocytic Leukemia (CLL), where you'll learn about its often asymptomatic nature, especially in older adults. Discover the vital role of flow cytometry in accurate diagnosis and the significance of chromosomal abnormalities in prognosis. Explore treatment strategies, including the use of BTK inhibitors and combination therapies. Tune in for insights on managing complications and approaches for relapsed cases that take patient prognosis into account.

Exploring neuroendocrine tumors, their diagnosis, signs, symptoms, and associated syndromes. Discussion on grading system, treatment approaches like surgery and somatostatin analogs. Focus on poorly differentiated grade three tumors with emphasis on chemotherapy, radiation, and specialized treatments.

This podcast covers tips for the hematology & oncology board exams, including NSCLC treatments and adjuvant chemotherapy. It discusses treatment strategies for breast cancer, bone metastases, and specialized therapies. They also review hemoglobinopathies, Von Willebrand disease, and bone marrow failure disorders. Additionally, the importance of supportive care and wellness during exam preparation is emphasized.

Explore the fascinating world of Von Willebrand Disease, a complex bleeding disorder affecting platelet function. Learn about its various types, including memorable mnemonics for distinguishing them. Discover the critical role of von Willebrand factor in blood clotting and how genetics influence diagnosis. Delve into treatment options, from using Desmopressin for milder cases to comprehensive therapies for more severe conditions. Plus, uncover the details of acquired Von Willebrand Disease and its links to autoimmune issues!

This podcast covers important topics on cervical cancer for health care providers, including prevention, risk factors, diagnosis, and treatment. It discusses reducing HPV rates, diagnostic methods, staging criteria, treatment options like hysterectomy and chemotherapy, and advancements in treatment strategies for metastatic or recurrent cervical cancer